Pre-exposure prophylaxis accessibility research and evaluation (PrEPARE Study)

AIDS and Behavior

Volumn 18, Issue 9, 2014, Pages 1722-1725

  King, Helen L ^a   Keller, Samuel B ^a   Giancola, Michael A ^a   Rodriguez, David A ^a   Chau, Jasmine J ^a   Young, Jason A ^a   Little, Susan J ^a   Smith, Davey M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIVIRUS AGENT; DEOXYCYTIDINE; EMTRICITABINE; PHOSPHONIC ACID DERIVATIVE; TENOFOVIR;

ADULT; ANALOGS AND DERIVATIVES; ATTITUDE TO HEALTH; ECONOMICS; EVALUATION STUDY; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH SURVEY; HIV INFECTIONS; HUMAN; MALE; MALE HOMOSEXUALITY; MIDDLE AGED; PATIENT ATTITUDE; PRE-EXPOSURE PROPHYLAXIS; PROCEDURES; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA; UNITED STATES; UNSAFE SEX;

ADENINE; ADULT; ANTI-HIV AGENTS; ANTIVIRAL AGENTS; CALIFORNIA; DEOXYCYTIDINE; EMTRICITABINE; HEALTH EXPENDITURES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HEALTH SURVEYS; HIV INFECTIONS; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; ORGANOPHOSPHONATES; PATIENT ACCEPTANCE OF HEALTH CARE; PRE-EXPOSURE PROPHYLAXIS; TENOFOVIR; UNSAFE SEX;

EID: 84906278530     PISSN: 10907165     EISSN: 15733254     Source Type: Journal    
DOI: 10.1007/s10461-014-0845-5     Document Type: Article

References (12)

1. Centers for Disease Control and Prevention. HIV in the United States: At a Glance. February 2013. http://www.cdc.gov/hiv/resources/factsheets/us.htm. Accessed March, 26 2012.
2. Grant RM, Lama JR, Anderson PL, McMahan V, Liu AY, Vargas L, et al. Preexposure chemoprophylaxis for HIV prevention in men who have sex with men. N Engl J Med. 2010;363(27):2587-99.
3. Anderson PL, Glidden DV, Liu A, Buchbinder S, Lama JR, Guanira JV, et al. Emtricitabine-tenofovir concentrations and pre-exposure prophylaxis efficacy in men who have sex with men. Sci Transl Med. 2012;4(151):151ra125.
4. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep. 2011 Jan 28;60(3):65-8.
5. Baeten JM, Donnell D, Ndase P, Mugo NR, Campbell JD, Wangisi J, et al. Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012;367(5):399-410.
6. Thigpen MC, Kebaabetswe PM, Paxton LA, Smith DK, Rose CE, Segolodi TM, et al. Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana. N Engl J Med. 2012;367(5):423-34 Epub 2012 Jul 11.
7. Brooks RA, Landovitz RJ, Kaplan RL, Lieber E, Lee SJ, Barkley TW. Sexual risk behaviors and acceptability of HIV pre-exposure prophylaxis among HIV-negative gay and bisexual men in serodiscordant relationships: a mixed methods study. AIDS Patient Care STDs. 2012;26(2):87-94.
8. Aghaizu A, Mercey D, Copas A, Johnson AM, Hart G, Nardone A. Who would use PrEP? Factors associated with intention to use among MSM in London: a community survey. Sex Transm Infect. 2013;89(3):207-11.
9. Mustanski B, Johnson AK, Garofalo R, Ryan D, Birkett M. Perceived likelihood of using HIV pre-exposure prophylaxis medications among young men who have sex with men. AIDS Behav. 2013;17(6):2173-9.
10. Krakower D, Mayer KH. Engaging healthcare providers to implement HIV pre-exposure prophylaxis. Curr Opin HIV AIDS. 2012;7(6):593-9.
11. Golub SA, Gamarel KE, Rendina HJ, Surace A, Lelutiu-Weinberger CL. From efficacy to effectiveness: facilitators and barriers to PrEP acceptability and motivations for adherence among MSM and transgender women in New York City. AIDS Patient Care STDS. 2013;27(4):248-54. doi: 10.1089/apc.2012.0419.
12. County of San Diego Health and Human Services Agency Division of Public Health Services Epidemiology and Immunization Services Branch HIV/AIDS Surveillance Program Epidemiology Report 2012. http://www.sdcounty.ca.gov/hhsa/ programs/phs/documents/HAEU-BiAnnual-Report-2012-final.pdf. Accessed 10 December, 2012.